Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

U.S. Complementary and Alternative Medicine Companies, Market Entry and Expansion Strategies

Date : 25 March 2026

Latest Updates of Key Players in the U.S. Complementary and Alternative Medicine Market

U.S. Complementary and Alternative Medicine Market Companies are Columbia Nutritional, Nordic Nutraceuticals, Ramamani Iyengar Memorial Yoga Institute, The Healing Company

Everything about the U.S. Complementary and Alternative Medicine Market, all in one place  Access the Dashboard

Company Profile

Company Headquarters Latest Update
Columbia Nutritional United States Columbia Nutritional LLC is recognized as a significant supplier, allowing smaller, boutique brands to scale their targeted botanical providing, serving the surging demand for tailored health services.
Nordic Nutraceuticals United States In February 2026, Nordic Group B.V., an international pharmaceutical organization operating as Nordic Pharma, announced the launch of Lacrifill®, a novel therapy for dry eye, to the European market.
Ramamani Iyengar Memorial Yoga Institute India Ramamani Iyengar Memorial Yoga Institute is the hub of Iyengar Yoga. providing both in-person and online therapeutic yoga sessions.
The Healing Company United States The company continues to focus on obtaining brands in the nutraceuticals, nutritional products, and holistic healing sectors.
SCHUMACHER YOGA United States Schumacher’s strategies emphasize Iyengar Yoga, which is broadly recognized as a CAM therapy that combines breathing, asana, and meditation to enhance health.
Pure Encapsulations, LLC United States Pure Encapsulations is considered a foremost contributor to the CAM market, providing products that help holistic health and preventive care.

Supply Chain Analysis

R&D:

  • Research and development (R&D) for U.S. complementary and alternative medicine includes clinical research and trials, product advancement and preclinical research, procedural research, digital and technical support, and consulting and standardization solutions.
  • Key Players: Nordic Nutraceuticals and Quantum Touch Inc.

Manufacturing Processes:

  • Manufacturing processes in Complementary and Alternative Medicine (CAM) are diverse, ranging from traditional manual methods to modernized, standardized industrial techniques, particularly within herbal medicine, Ayurveda, and Traditional Chinese Medicine (TCM).
  • Key Players: Nature's Bounty, AYUSH Ayurvedic

Patient Services:

  • Patient services for U.S. complementary and alternative medicine involve massage, acupuncture, chiropractic care, meditation, yoga, herbal remedies, and nutritional therapies.
  • Key Players: Pure Encapsulations and Herb Pharm

Market Growth

The U.S. complementary and alternative medicine market size was estimated at USD 52.84 billion in 2025 and is Complementary and Alternative Medicine predicted to increase from USD 67.55 billion in 2026 to approximately USD 616.07 billion by 2035, expanding at a CAGR of 27.84% from 2026 to 2035.

U.S. Complementary and Alternative Medicine Market Size is USD 67.55 Billion in 2026.

Recent Developments in the U.S. Complementary and Alternative Medicine Market

  • In January 2026, PlacidWay, a worldwide leader in healthcare tourism and cross-border healthcare services, announced the expansion of its worldwide offerings with the launch of PlacidWellness, an intended wellness tourism platform focused on substitute, complementary, and integrative medicine available to customers worldwide.
  • In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will allow it to enter and lead in fast-growing cancer diagnostics segments, helping millions more patients. Under the terms of the agreement, Exact Sciences stockholders will receive $105 per mutual share, showing a total equity value of approximately $21 billion.
  • In September 2025, PanGenomic Health Inc. is pleased to announce that its wholly-owned subsidiary, Mindleap Health Inc., is advancing a real-world evidence platform for the Complementary & Alternative Medicine market.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales